Pharmarama Launches New Website: http://www.pharamarama.com to Highlight Firm's Global Expertise in Comparator Trial Supply and Named Patient Programs

Share Article

Pharmarama, a leader in the procurement of pharmaceutical products for comparator trials and named patient programs, today announced the launch of its new corporate Website at http://www.pharmarama.com.

News Image
This new site will also serve as an interactive communication medium with our clients, keeping them up to date on the latest developments in the field and providing useful links to industry resources.

    The new Website coincides with the establishment of Pharmarama's U.S. sales and marketing office in Boston and highlights the firm's capabilities in the growing fields of comparator drug sourcing for clinical trials and providing drugs for named patient programs worldwide. The company maintains its headquarters in London, England and has additional offices in Germany.

"We are in such a dynamic business that we needed to have a site that provided our clients and prospects with easily accessible information about our company and its capabilities," said Tammy Bishop, Pharmarama's vice president of U.S. business development. "This new site will also serve as an interactive communication medium with our clients, keeping them up to date on the latest developments in the field and providing useful links to industry resources."

Pharmarama was founded in 2006 by Ben Rabin as the U.S. affiliate of U.K.-based BR Pharma Limited, which first gained recognition for obtaining regulatory permission to import Ritalin SR into the U.K. Rabin, a pharmacist with over 40 years in the retail and wholesale pharmaceutical industries, and BR Pharma have provided over a decade of service to the world's leading pharmaceutical companies and clinical research organizations sourcing and procuring pharmaceutical products for clinical trials, as well as providing services for named patient programs. Pharmarama works in collaboration with BR Pharma as a single point of contact for the sourcing, repacking, blinding and distribution of comparator drugs worldwide.

"We strived to create a site that would emphasize the key characteristics of the company - including its extensive track record, consultative approach to service and decades of experience in the supply of medicines worldwide," said Marcia Polese, principal of the integrated marketing firm Polese Clancy, which developed the site. "We focused on the terms reliability, flexibility and know-how to characterize the key differentiators of the firm and deployed navigation that highlights Pharmarama's named patient and comparator drug services."

Pharmarama's named patient programs allow for the supply and use of unlicensed medicines under strictly limited conditions to meet the special needs of a particular patient where a licensed equivalent does not exist. Named patient medicines include medicines that are not yet licensed in a territory, as well as investigational drugs awaiting approval. Pharmarama works with leading pharmaceutical companies in establishing formally structured named patient programs in the pre-launch phase of a medicine's lifecycle.

Comparator drugs are used in clinical trials to compare therapies under review to current therapies commercially available in the market. An estimated 20 percent of all clinical pharmaceutical studies globally use comparator products. Pharmarama provides validated comparator drug services - with speed, accuracy and the highest degree of ethical standards - to the world's leading pharmaceutical companies and clinical research organizations.

About Pharmarama

Pharmarama is a licensed wholesaler and importer of licensed and unlicensed medicines, based in London, England, with offices located in the United States and Germany. The company, in partnership with BR Pharma Limited, provides validated comparator drug services such as sourcing, supply chain management and support services, including drug warehousing, custom pharmaceutical manufacturing, packing and translation services.

For more information, please visit us on the Web at http://www.pharmarama.com or http://www.brpharmaltd.co.uk.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Paul Sagan
Sharon Merrill Associates, Inc.
617-542-5300
Email >